Alexander Ryckaert

Mr. Alexander Ryckaert

Laboratory of Pharmaceutical Process Analytical Technology
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ARAlexander Ryckaert
Alexander Ryckaert
MGMichael Ghijs
Michael Ghijs
CPChristoph Portier
Christoph Portier
DDDejan Djuric
Dejan Djuric
AFAdrian Funke
Adrian Funke
Thomas De BeerThomas De Beer
Thomas De Beer
The drying unit of a continuous from-powder-to-tablet manufacturing line based on twin-screw granulation (TSG) is a crucial intermediate process step to achieve the desired tablet quality. Understanding the size reduction of pharmaceutical granules before, during, and after the fluid bed drying process is, however, still lacking. A first major goal was to investigate the breakage and attrition phenomena during transport of wet and dry granules, the filling phase, and drying phase on a ConsiGma-25 system (C25). Pneumatic transport of the wet granules after TSG towards the dryer induced extensive breakage, whereas the turbulent filling and drying phase of the drying cells caused rather moderate breakage and attrition. Subsequently, the dry transfer line was responsible for additional extensive breakage and attrition. The second major goal was to compare the influence of drying air temperature and drying time on granule size and moisture content for granules processed with a commercial-scale ConsiGma-25 system and with the R&D-scale ConsiGma-1 (C1) system. Generally, the granule quality obtained after drying with C1 was not predictive for the C25, making it challenging during process development with the C1 to obtain representative granules for the C25.

1 August 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ARAlexander Ryckaert
Alexander Ryckaert
DHDaan Van Hauwermeiren
Daan Van Hauwermeiren
JDJ. Dhondt
J. Dhondt
AMAlexander De Man
Alexander De Man
AFAdrian Funke
Adrian Funke
Thomas De BeerThomas De Beer
Thomas De Beer

1 June 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ARAlexander Ryckaert
Alexander Ryckaert
FSFanny Stauffer
Fanny Stauffer
AFAdrian Funke
Adrian Funke
DDD. Djuric
D. Djuric
Valérie VanhoorneValérie Vanhoorne
Valérie Vanhoorne
Thomas De BeerThomas De Beer
Thomas De Beer

25 August 2021 in Processes
Verified
Journal Article
Open access
PDF file
KMKensaku Matsunami
Kensaku Matsunami
ARAlexander Ryckaert
Alexander Ryckaert
MPMichiel Peeters
Michiel Peeters
Sara BadrSara Badr
Sara Badr
Hirokazu SugiyamaHirokazu Sugiyama
Hirokazu Sugiyama
Thomas De BeerThomas De Beer
Thomas De Beer
Toward further implementation of continuous tablet manufacturing, one key issue is the time needed for start-up operation because it could lead to lower product yield and reduced economic performance. The behavior of the start-up operation is not well understood; moreover, the definition of the start-up time is still unclear. This work investigates the effects of process parameters on the start-up operation in continuous wet granulation, which is a critical unit operation in solid drug manufacturing. The profiles of torque and granule size distribution were monitored and measured for the first hour of operation, including the start-up phase. We analyzed the impact of process parameters based on design of experiments and performed an economic assessment to see the effects of the start-up operation. The torque profiles indicated that liquid-to-solid ratio and screw speed would affect the start-up operation, whereas different start-up behavior resulted in different granule size. Depending on the indicator used to define the start-up operation, the economic optimal point was significantly different. The results of this study stress that the start-up time differs according to the process parameters and used definition, e.g., indicators and criteria. This aspect should be considered for the further study and regulation of continuous manufacturing.

14 July 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
KYKeita Yaginuma
Keita Yaginuma
KMKensaku Matsunami
Kensaku Matsunami
LDLaure Descamps
Laure Descamps
ARAlexander Ryckaert
Alexander Ryckaert
TBThomas De Beer
Thomas De Beer

24 February 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MGMichael Ghijs
Michael Ghijs
ARAlexander Ryckaert
Alexander Ryckaert
DHDaan Van Hauwermeiren
Daan Van Hauwermeiren
Thomas De BeerThomas De Beer
Thomas De Beer